Lightning kills 320 million trees annually, climate change will escalate toll further
HQ Team August 12, 2025: A study published in the journal Global Change Biology has revealed that lightning kills approximately 320 million trees
Climate
Research
Health
FDA approves VIZZ eye drops: A new option for presbyopia
HQ Team August 11, 2025: The US Food and Drug Administration (FDA) has granted approval to VIZZ (aceclidine ophthalmic solution 1.44%), an innovative
Drugs
Research
Novartis’s Ianalumab has positive Phase III results for Sjögren’s Syndrome
HQ Team August. 11, 2025: Novartis AG announced positive Phase III trial results for its experimental autoimmune drug, Ianalumab (VAY736), in treating Sjögren’s
Health
Pharma
Research
UK researchers unravel 8 gene variants in chronic fatigue syndrome
About 67 million people globally living with chronic fatigue syndrome have different genes compared to their healthy counterparts, initial findings from the world's
Drugs
Health
Pharma
Jazz Pharma’s oral drug for a type of brain tumour gets US approval
Jazz Pharmaceuticals Plc’s treatment for a rare and aggressive brain tumour that affects children and adults got approval from the US regulator.
Health
Medical
Opinion
Hanuman Complex: An Indian take on positive psychology and its human effect
Hanuman complex is very much implied in positive psychology in this sense. It helps individuals to rediscover their hidden potential. Rooted in Hanuman’s
Drugs
Health
Pharma
Gates Foundation to spend $2.5 billion on women’s health innovations
The Gates Foundation will support more than 40 innovations in five chronically underfunded areas in women’s health by spending $2.5 billion over the
Health
Medical
Research
A 15-minute brisk walk may cut mortality rate by 20%: Vanderbilt
A 15-minute fast walk helped reduce mortality by 20%, mostly in low-income Black individuals in the US, a study finds.
Health
Research
Physicians using AI viewed as less competent and trustworthy
HQ Team August 2, 2025: A new study conducted by Moritz Reis from the University of Wuerzburg in Germany and colleagues has shed
Health
Research
Not all low-grade prostate cancers are low risk: New study finds 30% risk
HQ Team August 2, 2025: A study published in JAMA Oncology is challenging the conventional belief that men diagnosed with Grade Group One